SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
Spectral Medical Inc.
An SI Board Since October 2011
Posts SubjectMarks Bans Symbol
520 11 0 EDTXF
Emcee:  Sultan Type:  Unmoderated
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
520The topline results from the Tigris trial mark an important step forward in advaSultan-October 13
519Join the Sepsis Alliance Institute for an in-depth exploration of the TIGRIS triSultan-October 9
518Looks like Vantive is going full speed ahead to be ready to launch if and when FSultan-October 3
517Spectral Medical Announces Publication of EDEN Observational Study New Study StSultan-September 16
516A new publication in Critical Care Explorations highlights the critical relationSultan-September 9
515youtube.comSultan-September 9
514 Canada must put together plan to tackle sepsis, researchers warn By Adrian GhSultan-September 9
513 Spectral Medical Sponsors Unite for Sepsis Symposium, Chicago September 8 – 9, Sultan-September 8
512 Spectral Medical is a stock to buy now, this analyst says Paradigm Capital anaSultan-August 27
511TIGRIS Unlocked: Evidence to Impact Sepsis Alliance gratefully acknowledges theSultan-August 26
510 Spectral Medical Receives US$3 Million From Vantive TORONTO, Aug. 25, 2025Sultan-August 25
509Announcement of Spectral Medical’s Tigris Trial Topline Results for “TORAYMYXIN™Sultan-August 21
508If you have been following Spectral Medical Inc. Phase III Trial Results on SepsSultan-August 18
507Tigris Trial Topline Results Call Replay August 13, 2025 spectraldx.comSultan-August 13
506Spectral Medical and Vantive Announce Topline Results from Spectral’s Tigris TriSultan-August 12
505Spectral Medical Announces Second Quarter and Provides Corporate Update financeSultan-August 8
504Vantive’s Transformative Impact on Renal Care Vantive has the unique distinctioSultan-June 26
503Overview This agreement outlines the terms between Spectral Medical Inc. and VaSultan-May 22
502Spectral Medical Update as posted on Linkedin Today We’re pleased to share impoSultan-May 13
501Spectral Medical is “fundamentally undervalued”, Paradigm says [graphic] ParadiSultan-May 8
500Spectral Medical Announces Non-Dilutive Financing of Up to $10 Million with VantSultan-May 7
499The Tigris Trial and Corporate Update Call Join Chris Seto, Chief Executive OffSultan-May 6
498The TIGRIS Trial is a confirmatory study of Toraymyxin™ PMX Hemoperfusion in addSultan-April 28
497 Spectral Medical Completes Tigris Trial Enrollment 157 patients enrolledTopliSultan-April 16
496Spectral Medical Announces Fourth Quarter and Fiscal 2024 Results and Provides CSultan-March 27
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):